Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.
Trudy M. Krause, DrPH
Advertisement
Articles by Trudy M. Krause, DrPH
This study explored the statistical association of key social determinants of health with specific health outcomes to validate impact and then created weighted categorical matrices.
Advertisement
Latest Updated Articles
Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing PatternsPublished: August 15th 2025 | Updated:
- The Association of Social Determinants of Health With Health Outcomes
Published: March 9th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
2
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
3
First-Line Zongertinib Yields Strong Responses in Patients With Advanced HER2-Mutant NSCLC
4
New Biomarkers, Drug Targets Identified for Colorectal Cancer
5
